either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients;Carbonato cálcico o sevelamer reducen la excreción urinaria de oxalato en pacientes con insuficiencia renal avanzada

Nefrologia

Volumn 27, Issue 4, 2007, Pages 466-471

  Caravaca Magariños, Francisco ^a   Ruiz, A B ^a   Escola, J M ^a   Hernandez Gallego R ^a   Cerezo, I ^a   Fernandez N ^a   Barroso, S ^a   Martin M V ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Calcium carbonate; Chronic renal failure; Oxalate

Indexed keywords

CALCIUM CARBONATE; CHELATING AGENT; OXALIC ACID DERIVATIVE; POLYAMINE; SEVELAMER;

ARTICLE; CHRONIC KIDNEY FAILURE; CROSSOVER PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; URINE;

CALCIUM CARBONATE; CHELATING AGENTS; CROSS-OVER STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OXALATES; POLYAMINES;

EID: 38449109799     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Williams HE, Wandzilak TR: Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol 141: 742-749, 1989.
2. Boer P, Van Leersum L, Hene RJ, Mees EJ: Plasma oxalate concentration in chronic renal disease. Am J Kidney Dis 4: 118-122, 1984.
3. Ahmad S, Hatch M: Hyperoxalemia in renal failure and the role of hemoperfusion and hemodialysis in primary oxalosis. Nephron 41: 235-240, 1985.
4. Yamauchi A, Fujii M, Shirai D y cols.: Plasma concentration and peritoneal clearance of oxalate in patients on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 25: 181-185, 1986.
5. Worcester EM, Nakagawa Y, Bushinsky DA, Coe FL: Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest 77: 1888-1896, 1986.
6. Salyer WR, Keren D: Oxalosis as a complication of chronic renal failure. Kidney Int 4: 61-66, 1973.
7. Tomson CR, Channon SM, Parkinson IS y cols.: Plasma oxalate concentration and secondary oxalosis in patients with chronic renal failure. J Clin Pathol 41: 1107-1113, 1988.
8. Recht PA, Tepedino GJ, Siecke NW y cols.: Oxalic acid alters intracellular calcium in endothelial cells. Atherosclerosis 173: 321-328, 2004.
9. Brady HR, Fay WP, Meema HE, Rabinovich S, Rapoport A, Oreopoulos DG: Oxalate bone disease - an emerging form of renal osteodystrophy. Int J Artif Organs 12: 715-719, 1989.
10. Marangella M, Vitale C, Petrarulo M y cols.: Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure. Kidney Int 48: 182-187, 1995.
11. Tomson CR, Channon SM, Ward MK, Laker MF: Plasma oxalate concentration, oxalate clearance and cardiac function in patients receiving haemodialysis. Nephrol Dial Transplant 4: 792-799, 1989.
12. Hoffman GS, Schumacher HR, Paul H y cols.: Calcium oxalate microcrystalline-associated arthritis in end-stage renal disease. Ann Intern Med 97: 36-42, 1982.
13. Han HJ, Lim MJ, Lee YJ: Oxalate inhibits renal proximal tubule cell proliferation via oxidative stress, p38 MAPK/JNK, and cPLA2 signaling pathways. Am J Physiol Cell Physiol 287: C1058-C1066, 2004.
14. Truong LD, Yakupoglu U, Feig D y cols.: Calcium oxalate deposition in renal allografts: morphologic spectrum and clinical implications. Am J Transplant 4: 1338-1344, 2004.
15. Pinheiro HS, Camara NO, Osaki KS, De Moura LA, Pacheco-Silva A: Early presence of calcium oxalate deposition in kidney graft biopsies is associated with poor long-term graft survival. Am J Transplant 5: 323-329, 2005.
16. Sharma V, Schwille PO: Effect of calcium on oxalate uptake and transport by the rat intestine. Scand J Clin Lab Invest 52: 339-346, 1992.
17. Hess B, Jost C, Zipperle L, Takkinen R, Jaeger P: High-calcium intake abolishes hyperoxaluria and reduces urinary cristallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 13: 2241-2247, 1998.
18. Cizman B: Hyperphosphataemia and treatment with sevelamer in haemodialysis patients. Nephrol Dial Transplant 18 (Supl. 5): 47-49, 2003.
19. Braunlin W, Zhorov E, Guo A y cols.: Bile acid binding to sevelamer HCl. Kidney Int 62: 611-619, 2002.
20. Bergström J, Fürst P, Alvestrand A, Lindholm B: Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritonela dialysis. Kidney Int 44: 1048-1057, 1993.
21. Dobbins JW, Binder HJ: Effect of bile salts and fatty acids on the colonic absorption of oxalate. Gastroenterology 70: 1096-1100, 1976.
22. Caspary WF: Intestinal oxalate absorption. I. Absorption in vitro. Res Exp Med 171: 13-24, 1977.